Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3096 (LINC03096)

Target
LINC03096
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 3096 (LINC03096) is a human long intergenic non-coding RNA, defined as a class of RNA molecules longer than 200 nucleotides that do not overlap annotated coding regions and are transcribed from intergenic regions[3][5]. LINC03096, like other lincRNAs, is presumed to have a regulatory role in gene expression, chromatin architecture, and possibly in modulating transcription of neighboring genes, though its precise biological functions, disease relevance, and mechanisms remain uncharacterized[3]. There is no evidence that LINC03096 is a protein, receptor, enzyme, transporter, or other empirically validated drug target, and it currently lacks utility as a biomarker or disease indicator.

02

Mechanism of action

None for drugs, as it is not a validated pharmacological target.

03

Biological functions

Putative gene regulationChromatin and genome architecture modulationRNA stabilization and transcriptional regulation
04

Disease associations

None specific to LINC03096 have been reported; some lincRNAs are implicated in cancer or other diseases[3][7]. There is no direct evidence for LINC03096.
05

Safety considerations

None reported; as it is not a therapeutic target, no safety-related considerations exist.
06

Biomarkers

None specific to LINC03096. No evidence it is used as a biomarker.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3096 (LINC03096).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3096 (LINC03096).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call